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The Deficit Reduction Act (DRA) was passed late in 2005 and took effect at the beginning of 2007 [1-
4]. It had the effect of sharply reducing technical component payments for advanced imaging in private 
offices (including freestanding imaging centers). Prior to 2007, technical component payments for 
outpatient imaging were based on 2 different fee schedules. The Medicare Physician Fee Schedule 
(MPFS) applied to imaging done in offices, while the Hospital Outpatient Prospective Payment System 
(HOPPS) applied to imaging done in hospital outpatient facilities. For most types of MRI and CT 
examinations and some nuclear medicine examinations, the MPFS technical component payments to 
imaging offices had been considerably higher than those paid to hospitals under the HOPPS. The DRA 
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reduced payments for all office imaging to the lower of the 2 schedules. This resulted in dramatic cuts in 
Medicare revenues to owners of advanced imaging equipment in private offices. It was estimated that 
the average reduction in technical component payments in offices was 35% for MRI, 25% for MR 
angiography, 9% for CT, 37% for CT angiography, and 16% for nuclear medicine [5]. By making these 
cuts, federal policymakers hoped to save money by reducing the fees and also by reducing the incentive 
for physicians to place advanced imaging equipment in their offices. 
 
In 2008, the Government Accountability Office (GAO) issued its first report on the effect of the DRA on 
imaging costs [3,6]. It indicated that Medicare Part B spending for imaging had grown from $6.7 billion 
in 2000 to $13.8 billion in 2006. This had represented a compound annual growth rate (CAGR) of 
12.9% per year. But in 2007, the first year of the DRA, spending on imaging dropped to $12.1 billion - a 
decline of 12.9% from the previous year. Payments for the 3 advanced imaging modalities (MRI, CT, 
and nuclear medicine) dropped 14.8% in 2007. 
 
Not surprisingly, these steep cuts sparked dismay and anger within the radiology community. This was 
compounded by the fact that a number of commercial payers adopted similar cuts [7]. The ACR and the 
National Electrical Manufacturers Association (NEMA) and several other organizations jointly formed 
the Access to Medical Imaging Coalition (AMIC), which attempted to overturn the DRA [8], but to no 
avail. A number of web sites representing various organizations weighed in with commentary on the 
DRA, all of it expressing concerns about the effects of the Act [8-15]. The concerns were that private 
office imaging facilities would be forced to close, that advanced imaging exams might therefore have to 
be shifted to less convenient hospital outpatient departments, and that access for patients might be 
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jeopardized. Three years of nationwide Medicare data (2007-2009) is now available since the DRA took 
effect, and we wished to use these data to see if the Act has produced those effects. 
 
Methods and Materials 
We used the Medicare Physician/Supplier Procedure Summary Master Files (PSPSMFs) for 2000 
through 2009. These files cover all beneficiaries in the traditional Medicare fee-for-service program 
(34,938,000 in 2009) but not those in Medicare Advantage plans. For each code in the Current 
Procedural Terminology, Version 4 (CPT-4) manual, the files show procedure volume and other 
administrative data. We aggregated all the CPT-4 codes for CT and CT angiography, MRI and MR 
angiography, and nuclear medicine (including PET) and tracked outpatient volume changes in the 3 
modalities over the study period. Outpatient exams were identified by selecting Medicare’s location (or 
place-of-service) codes for  private offices (which includes freestanding imaging centers) and hospital 
outpatient departments (HOPDs). Private office data included facilities that were owned by radiologists, 
nonradiologist physicians, and companies or individual entrepreneurs who operated them as independent 
diagnostic testing facilities (IDTFs). Volumes were determined by tabulating global and professional 
component claims. Technical component claims were excluded to avoid double counting. All 
noninvasive diagnostic imaging claims were included, but claims for guidance of invasive procedures 
and for 3D rendering were not. In nuclear medicine, non-imaging function tests were excluded. For each 
of the 3 modalities, compound annual growth rates (CAGRs) were calculated from 2000 through 2006 
(before the DRA took effect) and compared with the CAGRs from  2007 through 2009 (after the DRA 
took effect). Comparison was also made of the trends in private offices and HOPDs.  
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The volumes reported here are complete population counts. Therefore, they do not require inferential 
statistics, which test the relationship of a sample to a population. 
 
Results 
Table 1 shows both private office and HOPD Medicare volumes for each of the 3 modalities in 2000, 
2006, and 2009. CAGRs (yearly growth) are shown for 2000-2006 and 2007-2009. Figures 1-3 show the 
growth trends for, respectively, CT, MRI, and nuclear medicine (including PET). 
 
As noted in Table 1, rapid outpatient growth occurred in all 3 modalities from 2000 through 2006, 
moreso in offices than in HOPDs. Yearly growth in all 3 modalities in both the office and HOPD 
settings was far higher before the DRA took effect (2000-2006) than after it (2007-2009). In the 2007-
2009 post-DRA period, the table compares volume changes in offices and HOPDs and reveals the 
following: CT grew more rapidly in offices than in HOPDs (CAGR of 2.1% vs. 0.5%). Nuclear 
medicine volumes declined in both locations, but the drop seen in offices (-1.7%) was less than that seen 
in HOPDs (-2.5%). MRI volumes declined slightly in offices (-1.1%) and increased slightly (1.0%) in 
HOPDs.  
 
Figure 1 shows the CT trends in offices and HOPDs. The large majority of these exams are done in 
HOPDs. In both settings, there was steady and rapid growth in the early years of the last decade. 
Flattening of the growth trend in HOPDs was first noted in 2006, and volumes remained generally stable 
thereafter, although a slight upturn occurred in 2009. In offices, steady growth occurred through 2007 
(the first year the DRA was in effect), then volumes remained stable during the last 2 years of the study.  
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Figure 2 shows the trends in MRI. Unlike CT, more of these exams have been done in offices in recent 
years than in hospitals. Rapid growth occurred in both settings in the early years of the last decade, but a 
slight flattening in the trendlines first appeared in 2005 and became quite apparent by 2006. Between 
then and 2009, volume rose very slightly in HOPDs and declined very slightly in offices. 
 
Nuclear medicine trends (including PET) are shown in Figure 3. In 2000, similar numbers of these 
exams were performed in offices and HOPDs but since then, growth in offices has been far more rapid. 
This primarily reflects the high usage of stress myocardial perfusion imaging by office-based 
cardiologists [16]. In offices, flattening of the rapid growth trend first became apparent in 2005. Office 
volume peaked in 2006, declined slightly in both 2007 and 2008, then declined more rapidly in 2009. In 
HOPDs, slow growth occurred from 2000 through 2004, followed by slow decline through 2009. 
Because PET is a relatively young technology that is of great interest, we have shown its growth in a 
separate graph in figure 4. The graph starts in 2002 because that is the first year in which PET was 
approved for reimbursement for some indications by Medicare. The overall volumes are much lower 
than those of the other modalities, but rapid growth can be seen in both the office and HOPD settings. 
Some of this is due to expansion of the indications for coverage in recent years. Growth occurred 
somewhat more rapidly in offices in the early years, but it began to slow somewhat in 2007 and by 2009 
a definite slowdown was in evidence. At that point, the volumes in the 2 settings were approximately 
equal. 
 
Total outpatient Medicare volumes (offices + HOPDs) for the 3 modalities in 2006 and 2009 were as 
follows: CT - 9,951,835 in 2006 vs. 10,265,955 in 2009 (+3.2%); MRI – 5,084,802 in 2006 vs. 
5,067,344 in 2009 (-0.3%); nuclear medicine 9,434,073 in 2006 vs. 8,897,663 in 2009 (-5.7%). 
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The percent share of all advanced imaging done in offices was 51.7% in 2006, compared with 51.3% in 
2009. 
 
Discussion 
As noted earlier, the DRA cuts posed 3 related questions or concerns from a health policy perspective. 
Would private office imaging facilities be forced to close? Would advanced imaging exams therefore 
have to be shifted to less convenient HOPDs? Would patient access to advanced imaging exams be 
jeopardized?  
 
There are no precise data available anywhere on how many imaging office facilities may have closed 
since the DRA took effect. Although some have undoubtedly closed, others may have opened. In areas 
where some offices have closed, other remaining offices may have had excess capacity and been able to 
absorb the exam volume that had been displaced by those closures. Among those that have closed, the 
reasons can be unclear and may have nothing to do with the DRA. For example, in our area, we are 
aware of IDTFs  that were closed because of mergers of their corporate owners. Other office facilities 
closed because of adverse reimbursement policies instituted by commercial payers, in addition to the 
cuts imposed by Medicare. If large scale closures of imaging offices had resulted from the DRA, one 
would have expected to see substantial decreases in Medicare office volumes of advanced imaging from 
2007-2009 and concomitant increases in HOPD volumes as exams shifted to the hospital facilities. The 
data in the Table and Figures 1-3 do not show either of these things happening.  On the contrary, after 
the DRA took effect (2007-2009 data), CT actually grew more rapidly in offices than in HOPDs ( 
CAGR of 2.1% vs. 0.5%). Nuclear medicine volumes decreased in both settings, but offices fared better 
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in that their volume loss was proportionately less than that in HOPDs (CAGR of -1.7% in offices vs. -
2.5% in HOPDs). In MRI, there were small losses in offices (-1.1%) and small gains in HOPDs 
(+1.0%). The PET trend in offices (Figure 4) showed definite slowing of the rapid growth in 2009, but a 
small increase in volume still occurred.  
 
In regard to access, there is no evidence that access to CT or MRI for Medicare beneficiaries was 
compromised to any great extent by the DRA. Compared with 2006, overall outpatient MRI volumes in 
2009 were largely unchanged and outpatient CT volumes were higher. Nuclear medicine presents a 
somewhat more worrisome picture, however. HOPD nuclear medicine volumes began to decline in 2005 
(Figure 3), well before the DRA. Office nuclear medicine, which is dominated by radionuclide 
myocardial perfusion imaging performed by cardiologists, began to show flattening in its growth in 
2005, reached a peak in 2006, dropped slightly in 2007 and 2008, then dropped somewhat more rapidly 
in 2009. From 2006 to 2009, overall outpatient nuclear medicine volume dropped 5.7%. Although there 
was no evidence of a shift from offices to HOPDs, this could signify loss of access to outpatient nuclear 
medicine for some seniors. To compound the problem, additional large cuts in reimbursements for 
radionuclide myocardial perfusion imaging were announced in late 2009 and scheduled to take effect in 
January 2010 [17].  
 
It seems apparent from this and other studies [18] that a dramatic slowdown in growth of imaging began 
around the middle of the last decade, after years of rapid increases. . The slowdown was not due to the 
DRA, or at least not solely to the DRA. The proof of this is that the slowdown was felt equally in 
HOPDs, which should not have been affected by the DRA. Moreover, the slowdown first became 
noticeable in 2005, even before the DRA was passed. There are several possible explanations for this 
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trend [18]. First, there has been extensive discussion in recent years within the health care industry about 
the need to reduce costs, and physicians may be getting more cost-conscious. Second, there has been 
concern expressed about radiation exposure [19-22] and ordering physicians may be responding to that. 
Third, both the American College of Radiology and the American College of Cardiology have 
developed appropriateness criteria for imaging [23-25], and physicians may be paying more attention to 
these criteria. Fourth, the recession could be implicated, although the slowdown predates the onset of the 
recession by several years. Fifth, the commercial payers have in some cases begun taking steps to limit 
the specialties that are eligible for reimbursement for advanced imaging [26], and this may have helped 
cut down on self-referral. Finally, radiology benefits management companies (RBMs) have instituted 
preauthorization programs within the commercially insured population in recent years. Preauthorization 
is now in widespread use and makes it somewhat more difficult and inconvenient for physicians to order 
advanced imaging studies. Although traditional fee-for-service Medicare has not yet employed 
preauthorization, it seems likely that the RBMs have influenced ordering physicians and induced them 
to think more carefully about what imaging tests they order (or whether they should order them at all). 
We believe that of the six factors discussed above, the RBMs are probably the principal one behind the 
growth slowdown reported herein. 
 
A possible limitation of this study is that we evaluated overall utilization of advanced imaging, but did 
not compare the trends among radiologists and nonradiologist physicians. To make such a comparison 
would have entailed using a different methodology, which was not compatible with the aims of this 
study. Such a comparison has been made in the past [4] with data from 2007, the first year the DRA was 
in effect.  
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There are several perspectives from which to view these data. From the perspective of health policy 
planners and federal government officials, the DRA appears to have achieved some of its goals. 
Payments for imaging were sharply reduced and it does not yet seem that access for seniors to CT and 
MRI has been compromised. Our perspective as radiologists is less sanguine, however. Nuclear 
medicine outpatient volume dropped 5.7% from 2006 to 2009, despite rapid growth in PET. This could 
signify loss of access to this modality for Medicare beneficiaries and be a harbinger of things to come in 
CT and MRI if further reimbursement cuts are imposed by the Centers for Medicare and Medicaid 
Services (CMS). If that happens, more closures of private office imaging facilities can be expected, and 
that will lead to a diversion of advanced imaging to HOPDs. Although Medicare reimbursements for 
advanced imaging to HOPDs and private offices are  
comparable, commercial health insurers pay HOPD rates that are often far higher than rates they pay to 
offices (F. Kyle, personal communication, June 2011). If the commercial payers are forced to pay more 
for outpatient advanced imaging because these studies are shifted to HOPDs, the extra costs will get 
passed on to consumers in the form of higher premiums. Moreover, patient copays in HOPDs are higher 
than in offices. Officials at CMS have to consider ramifications such as these. If CMS payment policies 
result in large scale closure of office imaging facilities, it could have a substantial adverse impact on 
patients enrolled in the commercial health insurance market. 
 
As radiologists, we can take some satisfaction in the remarkable flattening of the rapid growth in 
outpatient advanced imaging that our data demonstrate. This was a concern for health policy planners 
and now that growth has abated, there should be less downward pressure on imaging fees. Radiologists 
can also claim some credit for helping maintain access. In many instances, it is likely they were able to 
tighten their belts, institute new information technologies and work flows, and in general work harder 
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and more efficiently. This may have allowed them to keep their office facilities in operation despite 
lower Medicare revenues.  
 
In conclusion, we have examined recent trends in Medicare utilization of outpatient advanced imaging. 
There have been important developments. The rapid growth in outpatient CT and MRI that characterized 
the years prior to 2005 has largely abated. In nuclear medicine, there has actually been a substantial 
decline, despite rapid growth in PET. These changes do not appear to have been caused by the DRA, as 
there has not been a large shift of volume from offices to HOPDs. Although access for Medicare 
beneficiaries to outpatient CT and MRI does not yet appear to have been jeopardized, there is reason to 
be concerned about access to nuclear medicine, because of the nearly 6% drop in outpatient volume 
between 2006 and 2009. This could signify that the limits of resilience have been exceeded among some 
physicians in that discipline. Further cuts in Medicare reimbursements could bring about a similar 
situation in CT and MRI, and this could have adverse consequences not only for seniors but also for 
younger patients who are commercially insured. The complex interplay between physician fees and their 
willingness to provide services goes on and will have to be carefully watched in the coming years. 
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